<PAGE>
- -------------------------------------------------------------------------------
- -------------------------------------------------------------------------------
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
------------------------------
FORM 8-K
------------------------------
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934
AUGUST 1, 1997
--------------------------------
Date of Report (Date of earliest event reported)
HENRY SCHEIN, INC.
(Exact name of registrant as specified in its charter)
DELAWARE 0-27078 11-3136595
------------------ ------------------ -----------------
(State or other jurisdiction Commission File Number (I.R.S. Employer
of incorporation or Identification Number)
organization)
135 DURYEA ROAD, MELVILLE, NEW YORK 11747
------------------------------------------------
(Address of Principal Executive Offices) (Zip Code)
(516) 843-5500
-------------------------------------------------
(Registrant's telephone number, including area code)
NOT APPLICABLE
--------------------------------------------------
(Former name or former address, if changed since last report.)
- -------------------------------------------------------------------------------
- -------------------------------------------------------------------------------
<PAGE>
ITEM 2. ACQUISITION OR DISPOSITION OF ASSETS
Pursuant to the Agreement and Plan of Merger dated March 7, 1997, as
amended, among Henry Schein, Inc., a Delaware corporation ("Schein"), Micro
Bio-Medics, Inc., a New York corporation ("MBM"), and HSI Acquisition
corporation, a New York corporation and wholly-owned subsidiary of Schein
("Sub") (the "Merger Agreement"), the merger of Sub with and into MBM (the
"Merger") was consummated on August 1, 1997. Pursuant to the Merger, MBM became
a wholly-owned subsidiary of Schein and each of the shares of common stock, par
value $.03, of MBM that were outstanding immediately prior to the consummation
of the Merger were converted into the right to receive 0.62 shares of common
stock, par value $.01, of Schein. MBM distributes medical supplies to
physicians and hospitals in the New York metropolitan area, as well as to health
care professionals in the sports medicine, emergency medicine, school health,
industrial safety, government and laboratory markets nationwide. Schein filed a
Registration Statement on Form S-4 under the Securities Act of 1933,
Registration No. 333-30615, with the Securities and Exchange Commission on
July 2, 1997 relating to the Merger.
<PAGE>
ITEM 7. FINANCIAL STATEMENTS AND EXHIBITS.
(a) The following financial statements, including the related notes, of
MBM are filed as part of this report:
1. MBM's audited consolidated balance sheets as of November 30, 1996
and 1995 and the related audited consolidated statements of
income, cash flow and changes in stockholders' equity for each of
the three years in the period ended November 30, 1996.
(Incorporated by reference from MBM's Annual Report on Form
10-K/A for the fiscal year ended November 30, 1996.)
2. MBM's unaudited consolidated balance sheets as of February 28,
1997 and February 29, 1996 and the related unaudited consolidated
statements of income, cash flow and changes in stockholders'
equity for the three-month periods ended February 28, 1997 and
February 29, 1996. (Incorporated by reference to MBM's Quarterly
Report on Form 10-Q for the fiscal quarter ended February 28,
1997.)
(b) The unaudited pro forma combined condensed balance sheet dated as of
March 29, 1997, the unaudited pro forma combined condensed statements
of operations for each of the three years in the period ended December
28, 1996 and for the three-month period ended March 29, 1997 and the
related notes, set forth on pages 62 through 69 of Henry Schein,
Inc.'s Registration Statement on Form S-4, Registration No. 333-30615
(the "Registration Statement") under the caption "Unaudited Pro Forma
Combined Condensed Financial Statements" are incorporated herein by
reference.
(c) The following document is furnished as an Exhibit to this Current
Report on Form 8-K pursuant to Item 601 of Regulation S-K:
2. Agreement and Plan of Merger, dated March 7, 1997, as revised,
among Henry Schein, Inc., Micro Bio-Medics, Inc. and HSI
Acquisition Corp. (incorporated by reference to Exhibit 2.1 to
the Registration Statement).
<PAGE>
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
HENRY SCHEIN, INC
Date: August 5, 1997
By: /s/ Mark E. Mlotek
----------------------
Name: Mark E. Mlotek
Title: Vice President
<PAGE>
EXHIBIT INDEX
DOC. NO. DOCUMENT DESCRIPTION
2. Agreement and Plan of Merger, dated as of March 7, 1997, as
revised, among Henry Schein, Inc., Micro Bio-Medics, Inc. and HSI
Acquisition Corp. (incorporated by reference to Exhibit 2.1 to
the Registration Statement).
